DE3485128D1 - Zellinien verwendbar zur herstellung von hybridomazellen. - Google Patents

Zellinien verwendbar zur herstellung von hybridomazellen.

Info

Publication number
DE3485128D1
DE3485128D1 DE8484100548T DE3485128T DE3485128D1 DE 3485128 D1 DE3485128 D1 DE 3485128D1 DE 8484100548 T DE8484100548 T DE 8484100548T DE 3485128 T DE3485128 T DE 3485128T DE 3485128 D1 DE3485128 D1 DE 3485128D1
Authority
DE
Germany
Prior art keywords
production
cell lines
hybridoma cells
lines applicable
applicable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484100548T
Other languages
English (en)
Inventor
Toshihiro Nakanishi
Masashi Matsui
Kenju Matsunokichodanchi Miura
Yoshiaki Fukuda
Teruhisa Noguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58007744A external-priority patent/JPS59132885A/ja
Priority claimed from JP58007745A external-priority patent/JPH0679553B2/ja
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DE3485128D1 publication Critical patent/DE3485128D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
DE8484100548T 1983-01-20 1984-01-19 Zellinien verwendbar zur herstellung von hybridomazellen. Expired - Lifetime DE3485128D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58007744A JPS59132885A (ja) 1983-01-20 1983-01-20 新規細胞ライン
JP58007745A JPH0679553B2 (ja) 1983-01-20 1983-01-20 新規な雑種細胞

Publications (1)

Publication Number Publication Date
DE3485128D1 true DE3485128D1 (de) 1991-11-07

Family

ID=26342092

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484100548T Expired - Lifetime DE3485128D1 (de) 1983-01-20 1984-01-19 Zellinien verwendbar zur herstellung von hybridomazellen.

Country Status (12)

Country Link
US (1) US5126253A (de)
EP (1) EP0114670B1 (de)
KR (1) KR930005453B1 (de)
AU (1) AU569002B2 (de)
CA (1) CA1214123A (de)
CH (1) CH683526A5 (de)
DE (1) DE3485128D1 (de)
DK (1) DK23384A (de)
FR (1) FR2539759B1 (de)
GB (1) GB2134134B (de)
HU (1) HU191984B (de)
IL (1) IL70686A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693975A (en) * 1984-11-20 1987-09-15 The Wistar Institute Human hybridroma fusion partner for production of human monoclonal antibodies
US5126262A (en) * 1984-12-20 1992-06-30 Suntory Limited Monoclonal antibody
EP0185135A3 (de) * 1984-12-20 1988-07-13 Suntory Limited Monoklonaler Antikörper
US5106746A (en) * 1985-05-22 1992-04-21 E. I. Du Pont De Nemours And Company Process for the in vitro immunization of human splenocytes against tumor associated antigens
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
DE19634159C1 (de) * 1996-08-23 1997-09-25 Gsf Forschungszentrum Umwelt Induktion einer Tumorimmunität durch Injektion von Hybridzellen
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
EP1039933B8 (de) * 1997-11-10 2006-12-20 Cytimmune Sciences, Inc. Methoden und zusammensetzungen zur erhöhung der immunantwort und zur herstellung von in-vitro monoklonalen antikörpern (mabs)
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
CN1925843A (zh) 2003-12-02 2007-03-07 细胞免疫科学公司 生产单克隆抗体的方法和组合物
AU2005209318B2 (en) * 2004-01-28 2010-02-11 Cytimmune Sciences, Inc. Functionalized colloidal metal compositions and methods
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
EP2200932A4 (de) * 2007-09-21 2014-09-10 Cytimmune Sciences Inc Nanotherapeutische kolloidale metallzusammensetzungen und verfahren
EP2219458B1 (de) 2007-11-08 2015-07-15 Cytimmune Sciences, Inc. Zusammensetzungen und verfahren für die erzeugung von antikörpern

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
DE2757169A1 (de) * 1977-12-22 1979-07-05 Hoechst Ag Verfahren zur gewinnung insulin produzierender tierischer zellen
NZ198851A (en) * 1980-11-07 1984-07-31 Wistar Inst Stable,continuous human myeloma cell line capable of hybridisation with antibody-producing cells:production of hybrid cell line
AU530649B2 (en) * 1981-01-28 1983-07-21 Coats Patons Plc Method of manufacturing monoclonal antibodies and capable of manufacturing such antibodies
US4434230A (en) * 1981-08-12 1984-02-28 Research Corporation Human nonsecretory plasmacytoid cell line
JPS6011889B2 (ja) * 1981-10-28 1985-03-28 電気化学工業株式会社 継代可能なリンホカイン産生ヒトｔ細胞融合株及びその取得方法
GB2115005B (en) * 1981-12-03 1984-11-14 Cancer Research Campaign Anti rat liver monoclonal antibody
CA1213229A (en) * 1982-04-12 1986-10-28 Gary S. David Antibodies having dual specificities, their preparation and uses therefor
DE3245665A1 (de) * 1982-05-04 1983-11-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung permanenter tierischer und humaner zellinien und deren verwendung
US4693975A (en) * 1984-11-20 1987-09-15 The Wistar Institute Human hybridroma fusion partner for production of human monoclonal antibodies

Also Published As

Publication number Publication date
KR840007256A (ko) 1984-12-06
EP0114670A2 (de) 1984-08-01
IL70686A (en) 1988-07-31
IL70686A0 (en) 1984-04-30
DK23384D0 (da) 1984-01-19
HU191984B (en) 1987-04-28
CA1214123A (en) 1986-11-18
AU569002B2 (en) 1988-01-14
AU2351084A (en) 1984-07-26
GB2134134A (en) 1984-08-08
GB8401151D0 (en) 1984-02-22
GB2134134B (en) 1986-06-18
DK23384A (da) 1984-07-21
FR2539759B1 (fr) 1988-03-25
CH683526A5 (de) 1994-03-31
EP0114670B1 (de) 1991-10-02
KR930005453B1 (ko) 1993-06-22
US5126253A (en) 1992-06-30
FR2539759A1 (fr) 1984-07-27
EP0114670A3 (en) 1987-01-21

Similar Documents

Publication Publication Date Title
ES530360A0 (es) Celula solar.
DE3587868D1 (de) Verfahren zur Herstellung von Aerogelen.
DE3587035T2 (de) Wasserundurchlaessige, aber wasserdampfdurchlaessige folie und verfahren zu ihrer herstellung.
ATE102181T1 (de) Zwischenprodukte zur herstellung von 1,2,4triazolo(1,5-a>pyrimidin-2-sulfonamiden.
DE3381755D1 (de) Verfahren zur herstellung von diffraktionsgittern.
DE3583484D1 (de) Verfahren und zellinie zur kontinuierlichen herstellung von mit aids verwandten retrovieren (htlv-iii).
DE3280310D1 (de) Herstellung von polypeptiden in wirbeltierzellkulturen.
NO163870C (no) Elektrolysecelle.
DE3485128D1 (de) Zellinien verwendbar zur herstellung von hybridomazellen.
ATE18566T1 (de) Heterogene copolymeren des aethylens zur herstellung von filmen.
DE3481568D1 (de) Herstellung von photodioden.
ATA54881A (de) Kettengewirkte rohware zur herstellung von hoeschen
FI841344A (fi) Lockisolering foer en cell.
DE3485823T4 (de) Verfahren zur Herstellung von L-Tryptophan durch Gärung.
DE3382074D1 (de) Herstellung von hydroxyarylaldehyden.
DE3381907D1 (de) Herstellung von trifluormethylpyridinen.
DE3581238D1 (de) Mikrobiologische herstellung von l-phenylalanin.
ATE11521T1 (de) Verfahren zur herstellung von cyanwasserstoff.
AT373737B (de) Rohrelemente zur herstellung von rohrsystemen
AT373303B (de) Verfahren zur herstellung von zellstoffen mit niedrigem ligningehalt
ATE68012T1 (de) Zellinien verwendbar zur herstellung von hybridomazellen.
DE68918229T2 (de) Parentale Zellinien für die Herstellung von humanen Hybridomas.
NO870987L (no) Kontinuerlig gjŸringsprosess til fremstilling av bakterieceller.
DE3579392D1 (de) Verfahren zur mikrobiologischen herstellung von aldose-1-epimerase.
DE3575556D1 (de) Verfahren zur herstellung von 2-phenylbenztriazolen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee